vanadyl sulfate has been researched along with bis(maltolato)oxovanadium(iv) in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (55.56) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Diamond, J; Hei, YJ; McNeill, JH; Pelech, SL | 1 |
| McNeill, JH; Orvig, C; Yuen, VG | 1 |
| Battell, ML; McNeill, JH; Yao, J | 1 |
| Battell, M; Lyster, DM; McNeill, JH; Orvig, C; Ruth, TJ; Setyawati, IA; Sun, Y; Thompson, KH; Vo, C; Yuen, VG; Zeisler, S | 1 |
| Amin, SS; Brichard, SM; Buchet, JP; Crans, DC; Ongemba, LN; Reul, BA | 1 |
| Crans, DC; Goldfine, AB; Khan, HR; Kostyniak, PJ; McNeill, JH; Willsky, GR; Yang, LQ | 1 |
| Battell, M; McNeill, JH; Orvig, C; Thompson, KH; Tsukada, Y; Xu, Z | 1 |
| Aebischer, N; Hanson, GR; Lam, E; Liboiron, BD; Orvig, C; Thompson, KH | 1 |
| Adamczyk, A; Ciurkot, K; Dąbroś, W; Kordowiak, AM | 1 |
1 trial(s) available for vanadyl sulfate and bis(maltolato)oxovanadium(iv)
| Article | Year |
|---|---|
Effect of vanadium(IV) compounds in the treatment of diabetes: in vivo and in vitro studies with vanadyl sulfate and bis(maltolato)oxovandium(IV).
Topics: Animals; Apoproteins; Biological Availability; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Electron Spin Resonance Spectroscopy; Fasting; Humans; Hypoglycemic Agents; Immunoglobulin G; Male; Pyrones; Rats; Rats, Wistar; Serum Albumin; Streptozocin; Transferrin; Treatment Outcome; Vanadates; Vanadium; Vanadium Compounds | 2001 |
8 other study(ies) available for vanadyl sulfate and bis(maltolato)oxovanadium(iv)
| Article | Year |
|---|---|
Skeletal muscle mitogen-activated protein kinases and ribosomal S6 kinases. Suppression in chronic diabetic rats and reversal by vanadium.
Topics: Animals; Calcium-Calmodulin-Dependent Protein Kinases; Chromatography, Ion Exchange; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Insulin; Insulin Resistance; Kinetics; Muscle, Skeletal; Protein Serine-Threonine Kinases; Pyrones; Rats; Rats, Wistar; Reference Values; Ribosomal Protein S6 Kinases; Ribosomes; Time Factors; Vanadates; Vanadium; Vanadium Compounds | 1995 |
Comparison of the glucose-lowering properties of vanadyl sulfate and bis(maltolato)oxovanadium(IV) following acute and chronic administration.
Topics: Administration, Oral; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Hypoglycemic Agents; Injections, Intraperitoneal; Injections, Intravenous; Male; Pyrones; Rats; Rats, Wistar; Time Factors; Vanadates; Vanadium Compounds | 1995 |
Acute and chronic response to vanadium following two methods of streptozotocin-diabetes induction.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Fatty Acids, Nonesterified; Glucose Tolerance Test; Hypoglycemic Agents; Insulin; Pyrones; Rats; Rats, Sprague-Dawley; Rats, Wistar; Streptozocin; Triglycerides; Vanadates; Vanadium Compounds | 1997 |
Kinetic analysis and comparison of uptake, distribution, and excretion of 48V-labeled compounds in rats.
Topics: Animals; Computer Simulation; Hypoglycemic Agents; Male; Models, Biological; Pyrones; Rats; Rats, Wistar; Tissue Distribution; Vanadates; Vanadium Compounds | 1998 |
Effects of vanadium complexes with organic ligands on glucose metabolism: a comparison study in diabetic rats.
Topics: Administration, Oral; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Disinfectants; Glucokinase; Glucose; Hydroxybutyrates; Hypoglycemic Agents; Injections, Intraperitoneal; Insulin; Islets of Langerhans; Ligands; Liver; Liver Glycogen; Male; Muscles; Organometallic Compounds; Pentanones; Phosphoenolpyruvate Carboxykinase (GTP); Pyrones; Pyruvate Kinase; Rats; Rats, Wistar; RNA, Messenger; Time Factors; Vanadates; Vanadium Compounds | 1999 |
Influence of chelation and oxidation state on vanadium bioavailability, and their effects on tissue concentrations of zinc, copper, and iron.
Topics: Animals; Biological Availability; Bone and Bones; Caco-2 Cells; Copper; Humans; Iron; Kidney; Male; Oxidation-Reduction; Pyrones; Rats; Rats, Wistar; Vanadates; Vanadium; Vanadium Compounds; Zinc | 2002 |
New insights into the interactions of serum proteins with bis(maltolato)oxovanadium(IV): transport and biotransformation of insulin-enhancing vanadium pharmaceuticals.
Topics: Apoproteins; Biotransformation; Drug Synergism; Electron Spin Resonance Spectroscopy; Humans; Imidazoles; Insulin; Kinetics; Molecular Weight; Pyrones; Serum Albumin; Transferrin; Vanadates; Vanadium Compounds | 2005 |
Vanadium compounds affect growth and morphology of human rhabdomyosarcoma cell line.
Topics: Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cell Survival; Cytoplasm; Drug Screening Assays, Antitumor; Humans; Pyrones; Rhabdomyosarcoma; Vanadates; Vanadium Compounds | 2011 |